BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ·Healthcare·Biotechnology
$55.81
-0.57%
Mkt Cap $11.33B
Analyst Ratings
Buy
18
Hold
7
Sell
0
Price Target (82 analysts)
$90.88
Range $59.00 – $124.00
Implied Upside
+62.8%
Consensus $90.88 vs current $55.81
NASDAQ·Healthcare·Biotechnology
$55.81
-0.57%
Mkt Cap $11.33B
Buy
18
Hold
7
Sell
0
Price Target (82 analysts)
$90.88
Range $59.00 – $124.00
+62.8%
Consensus $90.88 vs current $55.81